Gland Pharma surges as Q2 PAT jumps 58% to Rs 291 crore
Mumbai, Nov. 9 -- On a sequential basis, net profit declined 8.3% from Rs 317 crore in Q1 FY27.
Revenue from operations increased 23.3% YoY to Rs 1,833.6 crore from Rs 1,486.9 crore. Sequentially, revenue rose 1.8% from Rs 1,800.3 crore.
Gross profit increased 24.7% YoY to Rs 1,163.8 crore from Rs 933.1 crore. Gross profit margin remained unchanged at 63% compared with the year-ago quarter, while it declined from 65% in Q1 FY27.
EBITDA increased 53.0% YoY to Rs 480.4 crore from Rs 313.9 crore. Sequentially, EBITDA declined 2.6% from Rs 493 crore. EBITDA margin improved to 26% from 21% a year ago but declined from 27% in the previous quarter.
Adjusted EBITDA rose 49.9% YoY to Rs 503 crore from Rs 335.5 crore. Adjusted EBITDA margin imp...
Click here to read full article from source
इस लेख के रीप्रिंट को खरीदने या इस प्रकाशन का पूरा फ़ीड प्राप्त करने के लिए, कृपया
हमे संपर्क करें.